Loading…

Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation

It has been shown recently that delayed transfers improve implantation rates in assisted reproductive technology programmes. In a prospective study, the pregnancy rates and safety of outcome were evaluated in a group of patients after the transfer of day 5 blastocysts with enzymatic treatment of the...

Full description

Saved in:
Bibliographic Details
Published in:Human reproduction (Oxford) 1998-10, Vol.13 (10), p.2926-2932
Main Authors: Fong, C Y, Bongso, A, Ng, S C, Kumar, J, Trounson, A, Ratnam, S
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c471t-e79f8f708e31f953216174b67c9ab243c1f1411ec483d2d01f93f1644200aca63
cites
container_end_page 2932
container_issue 10
container_start_page 2926
container_title Human reproduction (Oxford)
container_volume 13
creator Fong, C Y
Bongso, A
Ng, S C
Kumar, J
Trounson, A
Ratnam, S
description It has been shown recently that delayed transfers improve implantation rates in assisted reproductive technology programmes. In a prospective study, the pregnancy rates and safety of outcome were evaluated in a group of patients after the transfer of day 5 blastocysts with enzymatic treatment of the zona pellucida. Nineteen women with a mean age of 32.6+/-5.2 years and mean 2.1+/-2.2 repeated attempts had blastocyst transfers with a mean number of 2.5+/-0.7 embryos replaced per patient. The clinical pregnancy rates per cycle/transfer and implantation rate were 53% and 33%, respectively. The multiple pregnancy rate was 40% (two pregnancies were triplets). The pregnancy and implantation rates were very much higher than observed for most assisted reproduction technology centres. The 'in-vitro implantation' rates of zona-free blastocysts on a variety of feeder monolayers was 92%, offering some thoughts as to the role of the zona and interaction of the inner cell mass and trophoectoderm with the endometrium in implantation. Based on the in-vitro studies and the high multiple pregnancy rates, it appears that zona-manipulated blastocysts implant relatively well and there would be a need to reduce the number of transferred embryos to one or two, thus reducing multiple pregnancies and having spare blastocysts available for cryopreservation. The results also suggest that using the embryo culture protocol and method of transfer in the present study offers encouraging improvements to assisted reproduction technology, and enzymatic treatment of the zona may allow better anchorage and dialogue of the embryo with the endometrium, helping us to improve and understand implantation.
doi_str_mv 10.1093/humrep/13.10.2926
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70037849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humrep/13.10.2926</oup_id><sourcerecordid>70037849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-e79f8f708e31f953216174b67c9ab243c1f1411ec483d2d01f93f1644200aca63</originalsourceid><addsrcrecordid>eNqNkE9v3CAQxVHVKtn8-QA9ROJQ9RQnDLDY7i2N0iZSpF6SszWLoaGywQUcafecDx42u8o5Fxh4v3kwj5CvwC6AteLyaR6jmS5BlOMFb7n6RBYgFau4WLLPZMG4aioABYfkKKV_jJWyUQfkoG2Y5Mt6QV5-Dphy0OuUaY7okzWRos1lNX6zHjE7XQSDeTQ-02BpfjJ0EzzSyQzDrF2PP6gbpxienf9Lna-eXY6BFp_sBrcpBsFT9D2dfW9iyqV8A8dpQJ_f5BPyxeKQzOl-PyaPv24erm-r-z-_766v7ista8iVqVvb2Jo1RoBtl4KXaWq5UrVuccWl0GBBAhgtG9HznhVIWFBScsZQoxLH5PvOt_z2_2xS7kaXdBkDvQlz6mrGRN3ItoCwA3UMKUVjuym6EeO6A9Ztk-92yXcgtjfb5EvP2d58Xo2mf-_YR130b3sdk8bBlrC1S-8YLxAoXrDzHRbm6QOvvgKSC57m</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70037849</pqid></control><display><type>article</type><title>Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation</title><source>Oxford Journals Online</source><creator>Fong, C Y ; Bongso, A ; Ng, S C ; Kumar, J ; Trounson, A ; Ratnam, S</creator><creatorcontrib>Fong, C Y ; Bongso, A ; Ng, S C ; Kumar, J ; Trounson, A ; Ratnam, S</creatorcontrib><description>It has been shown recently that delayed transfers improve implantation rates in assisted reproductive technology programmes. In a prospective study, the pregnancy rates and safety of outcome were evaluated in a group of patients after the transfer of day 5 blastocysts with enzymatic treatment of the zona pellucida. Nineteen women with a mean age of 32.6+/-5.2 years and mean 2.1+/-2.2 repeated attempts had blastocyst transfers with a mean number of 2.5+/-0.7 embryos replaced per patient. The clinical pregnancy rates per cycle/transfer and implantation rate were 53% and 33%, respectively. The multiple pregnancy rate was 40% (two pregnancies were triplets). The pregnancy and implantation rates were very much higher than observed for most assisted reproduction technology centres. The 'in-vitro implantation' rates of zona-free blastocysts on a variety of feeder monolayers was 92%, offering some thoughts as to the role of the zona and interaction of the inner cell mass and trophoectoderm with the endometrium in implantation. Based on the in-vitro studies and the high multiple pregnancy rates, it appears that zona-manipulated blastocysts implant relatively well and there would be a need to reduce the number of transferred embryos to one or two, thus reducing multiple pregnancies and having spare blastocysts available for cryopreservation. The results also suggest that using the embryo culture protocol and method of transfer in the present study offers encouraging improvements to assisted reproduction technology, and enzymatic treatment of the zona may allow better anchorage and dialogue of the embryo with the endometrium, helping us to improve and understand implantation.</description><identifier>ISSN: 0268-1161</identifier><identifier>EISSN: 1460-2350</identifier><identifier>DOI: 10.1093/humrep/13.10.2926</identifier><identifier>PMID: 9804257</identifier><identifier>CODEN: HUREEE</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Biological and medical sciences ; Birth control ; Blastocyst - drug effects ; Blastocyst - physiology ; Embryo Implantation - drug effects ; Embryo Implantation - physiology ; Embryo Transfer - adverse effects ; Embryo Transfer - methods ; Female ; Fertilization in Vitro ; Gynecology. Andrology. Obstetrics ; Humans ; In Vitro Techniques ; Infertility - therapy ; Male ; Medical sciences ; Pregnancy ; Pregnancy Rate ; Pregnancy, Multiple ; Pronase - pharmacology ; Prospective Studies ; Safety ; Sterility. Assisted procreation ; Zona Pellucida - drug effects ; Zona Pellucida - physiology</subject><ispartof>Human reproduction (Oxford), 1998-10, Vol.13 (10), p.2926-2932</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-e79f8f708e31f953216174b67c9ab243c1f1411ec483d2d01f93f1644200aca63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2425162$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9804257$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fong, C Y</creatorcontrib><creatorcontrib>Bongso, A</creatorcontrib><creatorcontrib>Ng, S C</creatorcontrib><creatorcontrib>Kumar, J</creatorcontrib><creatorcontrib>Trounson, A</creatorcontrib><creatorcontrib>Ratnam, S</creatorcontrib><title>Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation</title><title>Human reproduction (Oxford)</title><addtitle>Hum Reprod</addtitle><addtitle>Hum Reprod</addtitle><description>It has been shown recently that delayed transfers improve implantation rates in assisted reproductive technology programmes. In a prospective study, the pregnancy rates and safety of outcome were evaluated in a group of patients after the transfer of day 5 blastocysts with enzymatic treatment of the zona pellucida. Nineteen women with a mean age of 32.6+/-5.2 years and mean 2.1+/-2.2 repeated attempts had blastocyst transfers with a mean number of 2.5+/-0.7 embryos replaced per patient. The clinical pregnancy rates per cycle/transfer and implantation rate were 53% and 33%, respectively. The multiple pregnancy rate was 40% (two pregnancies were triplets). The pregnancy and implantation rates were very much higher than observed for most assisted reproduction technology centres. The 'in-vitro implantation' rates of zona-free blastocysts on a variety of feeder monolayers was 92%, offering some thoughts as to the role of the zona and interaction of the inner cell mass and trophoectoderm with the endometrium in implantation. Based on the in-vitro studies and the high multiple pregnancy rates, it appears that zona-manipulated blastocysts implant relatively well and there would be a need to reduce the number of transferred embryos to one or two, thus reducing multiple pregnancies and having spare blastocysts available for cryopreservation. The results also suggest that using the embryo culture protocol and method of transfer in the present study offers encouraging improvements to assisted reproduction technology, and enzymatic treatment of the zona may allow better anchorage and dialogue of the embryo with the endometrium, helping us to improve and understand implantation.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Birth control</subject><subject>Blastocyst - drug effects</subject><subject>Blastocyst - physiology</subject><subject>Embryo Implantation - drug effects</subject><subject>Embryo Implantation - physiology</subject><subject>Embryo Transfer - adverse effects</subject><subject>Embryo Transfer - methods</subject><subject>Female</subject><subject>Fertilization in Vitro</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Infertility - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pregnancy</subject><subject>Pregnancy Rate</subject><subject>Pregnancy, Multiple</subject><subject>Pronase - pharmacology</subject><subject>Prospective Studies</subject><subject>Safety</subject><subject>Sterility. Assisted procreation</subject><subject>Zona Pellucida - drug effects</subject><subject>Zona Pellucida - physiology</subject><issn>0268-1161</issn><issn>1460-2350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqNkE9v3CAQxVHVKtn8-QA9ROJQ9RQnDLDY7i2N0iZSpF6SszWLoaGywQUcafecDx42u8o5Fxh4v3kwj5CvwC6AteLyaR6jmS5BlOMFb7n6RBYgFau4WLLPZMG4aioABYfkKKV_jJWyUQfkoG2Y5Mt6QV5-Dphy0OuUaY7okzWRos1lNX6zHjE7XQSDeTQ-02BpfjJ0EzzSyQzDrF2PP6gbpxienf9Lna-eXY6BFp_sBrcpBsFT9D2dfW9iyqV8A8dpQJ_f5BPyxeKQzOl-PyaPv24erm-r-z-_766v7ista8iVqVvb2Jo1RoBtl4KXaWq5UrVuccWl0GBBAhgtG9HznhVIWFBScsZQoxLH5PvOt_z2_2xS7kaXdBkDvQlz6mrGRN3ItoCwA3UMKUVjuym6EeO6A9Ztk-92yXcgtjfb5EvP2d58Xo2mf-_YR130b3sdk8bBlrC1S-8YLxAoXrDzHRbm6QOvvgKSC57m</recordid><startdate>19981001</startdate><enddate>19981001</enddate><creator>Fong, C Y</creator><creator>Bongso, A</creator><creator>Ng, S C</creator><creator>Kumar, J</creator><creator>Trounson, A</creator><creator>Ratnam, S</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19981001</creationdate><title>Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation</title><author>Fong, C Y ; Bongso, A ; Ng, S C ; Kumar, J ; Trounson, A ; Ratnam, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-e79f8f708e31f953216174b67c9ab243c1f1411ec483d2d01f93f1644200aca63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Birth control</topic><topic>Blastocyst - drug effects</topic><topic>Blastocyst - physiology</topic><topic>Embryo Implantation - drug effects</topic><topic>Embryo Implantation - physiology</topic><topic>Embryo Transfer - adverse effects</topic><topic>Embryo Transfer - methods</topic><topic>Female</topic><topic>Fertilization in Vitro</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Infertility - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pregnancy</topic><topic>Pregnancy Rate</topic><topic>Pregnancy, Multiple</topic><topic>Pronase - pharmacology</topic><topic>Prospective Studies</topic><topic>Safety</topic><topic>Sterility. Assisted procreation</topic><topic>Zona Pellucida - drug effects</topic><topic>Zona Pellucida - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fong, C Y</creatorcontrib><creatorcontrib>Bongso, A</creatorcontrib><creatorcontrib>Ng, S C</creatorcontrib><creatorcontrib>Kumar, J</creatorcontrib><creatorcontrib>Trounson, A</creatorcontrib><creatorcontrib>Ratnam, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fong, C Y</au><au>Bongso, A</au><au>Ng, S C</au><au>Kumar, J</au><au>Trounson, A</au><au>Ratnam, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation</atitle><jtitle>Human reproduction (Oxford)</jtitle><stitle>Hum Reprod</stitle><addtitle>Hum Reprod</addtitle><date>1998-10-01</date><risdate>1998</risdate><volume>13</volume><issue>10</issue><spage>2926</spage><epage>2932</epage><pages>2926-2932</pages><issn>0268-1161</issn><eissn>1460-2350</eissn><coden>HUREEE</coden><abstract>It has been shown recently that delayed transfers improve implantation rates in assisted reproductive technology programmes. In a prospective study, the pregnancy rates and safety of outcome were evaluated in a group of patients after the transfer of day 5 blastocysts with enzymatic treatment of the zona pellucida. Nineteen women with a mean age of 32.6+/-5.2 years and mean 2.1+/-2.2 repeated attempts had blastocyst transfers with a mean number of 2.5+/-0.7 embryos replaced per patient. The clinical pregnancy rates per cycle/transfer and implantation rate were 53% and 33%, respectively. The multiple pregnancy rate was 40% (two pregnancies were triplets). The pregnancy and implantation rates were very much higher than observed for most assisted reproduction technology centres. The 'in-vitro implantation' rates of zona-free blastocysts on a variety of feeder monolayers was 92%, offering some thoughts as to the role of the zona and interaction of the inner cell mass and trophoectoderm with the endometrium in implantation. Based on the in-vitro studies and the high multiple pregnancy rates, it appears that zona-manipulated blastocysts implant relatively well and there would be a need to reduce the number of transferred embryos to one or two, thus reducing multiple pregnancies and having spare blastocysts available for cryopreservation. The results also suggest that using the embryo culture protocol and method of transfer in the present study offers encouraging improvements to assisted reproduction technology, and enzymatic treatment of the zona may allow better anchorage and dialogue of the embryo with the endometrium, helping us to improve and understand implantation.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>9804257</pmid><doi>10.1093/humrep/13.10.2926</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-1161
ispartof Human reproduction (Oxford), 1998-10, Vol.13 (10), p.2926-2932
issn 0268-1161
1460-2350
language eng
recordid cdi_proquest_miscellaneous_70037849
source Oxford Journals Online
subjects Adult
Biological and medical sciences
Birth control
Blastocyst - drug effects
Blastocyst - physiology
Embryo Implantation - drug effects
Embryo Implantation - physiology
Embryo Transfer - adverse effects
Embryo Transfer - methods
Female
Fertilization in Vitro
Gynecology. Andrology. Obstetrics
Humans
In Vitro Techniques
Infertility - therapy
Male
Medical sciences
Pregnancy
Pregnancy Rate
Pregnancy, Multiple
Pronase - pharmacology
Prospective Studies
Safety
Sterility. Assisted procreation
Zona Pellucida - drug effects
Zona Pellucida - physiology
title Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T19%3A58%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blastocyst%20transfer%20after%20enzymatic%20treatment%20of%20the%20zona%20pellucida:%20improving%20in-vitro%20fertilization%20and%20understanding%20implantation&rft.jtitle=Human%20reproduction%20(Oxford)&rft.au=Fong,%20C%20Y&rft.date=1998-10-01&rft.volume=13&rft.issue=10&rft.spage=2926&rft.epage=2932&rft.pages=2926-2932&rft.issn=0268-1161&rft.eissn=1460-2350&rft.coden=HUREEE&rft_id=info:doi/10.1093/humrep/13.10.2926&rft_dat=%3Cproquest_cross%3E70037849%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c471t-e79f8f708e31f953216174b67c9ab243c1f1411ec483d2d01f93f1644200aca63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70037849&rft_id=info:pmid/9804257&rft_oup_id=10.1093/humrep/13.10.2926&rfr_iscdi=true